Jung‐Hwan Yoon

Seoul National University — South Korea

Medicine · Health Sciences

73h-index20.2kcitations699works7.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(262), Hepatocellular Carcinoma Treatment and Prognosis(236), Hepatitis B Virus Studies(153), Hepatitis C virus research(122), Liver Disease and Transplantation(87)

Publications694 total

Associations between steatotic liver disease subtypes and incident diabetes in young Korean adults: A nationwide cohort study
Diabetes Obesity and Metabolism·2025Open Access
Refined photobiomodulation therapy ameliorates inflammatory bowel disease via modulation of immune pathways and gut microbiota
Journal of Photochemistry and Photobiology B Biology·2025
Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis
Clinical and Molecular Hepatology·2025Open Access
Supplementary Figure S1 from A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
2025Open Access
Supplementary Figure S2 from A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
2025Open Access
Supplementary Tables S1-S9 from A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
2025Open Access
Supplementary Materials 1 from A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
2025Open Access
Supplementary Figure S4 from A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
2025Open Access
Supplementary Figure S3 from A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
2025Open Access
Supplementary Figure S5 from A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
2025Open Access
Prognostic Impact of Varices and Hemorrhagic Events in Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab
Gut and Liver·2025Open Access
A11YN: aligning LLMs for accessible web UI code generation
arXiv (Cornell University)·2025Open Access
Adverse Event Monitoring with Imaging: Prognostic Significance in Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma
Liver Cancer·2025Open Access
Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis
Diagnostic and Interventional Imaging·2025· 2 cited
Alternative Surveillance Improves Outcomes by Detecting Early-Stage Hepatocellular Carcinoma in Chronic Hepatitis B Patients
Gut and Liver·2025Open Access
Associations between steatotic liver disease subtypes and incident atrial fibrillation in young adults: a nationwide cohort study
Cardiovascular Diabetology·2025· 1 citedOpen Access
Correction: Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis
Osteoporosis International·2025Open Access
Comparison of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Steatotic Liver Disease
Gut and Liver·2025Open Access
Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis
Osteoporosis International·2025
All-cause and disease-specific mortality in young adults with MASLD: A nationwide cohort study
JHEP Reports·2025· 4 citedOpen Access
page 1 of 35Next →

Frequent Co-authors

Yoon Jun Kim(24), Jeong‐Hoon Lee(14), Hyo-Suk Lee(12), Su Jong Yu(10), Won Kim(9), Kyung‐Suk Suh(8), Donghee Kim(7), Gregory J. Gores(7), Chung Yong Kim(7), Nam‐Joon Yi(7), Goh Eun Chung(6), Hwi Young Kim(6), Jeong Heo(6), Masatoshi Kudo(5), Won Young Tak(5), Jeong Min Lee(5), Dong Hyeon Lee(5), Geum‐Youn Gwak(4), Jin Wook Chung(4), Stephen L. Chan(4)